# A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).

> **NCT02358629** · NA · COMPLETED · sponsor: **Nitiloop Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Chronic Total Occlusion

## Interventions

- **DEVICE:** NovaCross™ microcatheter

## Key facts

- **NCT ID:** NCT02358629
- **Lead sponsor:** Nitiloop Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02358629

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02358629, "A Prospective, Non-randomized Study to Evaluate the Safety and Performance of the NovaCross™ Microcatheter in Femoropopliteal Chronic Total Occlusion (CTO).". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02358629. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*